What Researchers Did
Researchers analyzed the outcomes of hyperbaric therapy in 145 cases of altitude decompression sickness, including 120 from U.S. Air Force chambers and 25 from other facilities.
What They Found
The study confirmed existing treatment recommendations for altitude decompression sickness, which involve immediate compression to 2.8 ATA (60 FSW) followed by intermittent oxygen and air breathing during slow decompression. This approach was based on the management experience of 145 cases, with initial treatments using compressed air showing varying success.
What This Means for Canadian Patients
Canadian patients experiencing altitude decompression sickness, particularly those in aviation or high-altitude occupations, could benefit from prompt hyperbaric oxygen therapy following established protocols. Access to specialized hyperbaric facilities and trained medical personnel is crucial for effective management of such cases.
Canadian Relevance
This study has no direct Canadian connection, as it focuses on cases within the U.S. military aerospace medicine context. However, the medical principles of hyperbaric therapy for decompression sickness are universally applicable.
Study Limitations
The study's conclusions are based on retrospective treatment experience and a survey of facilities, rather than a prospective, controlled clinical trial.